1. Home
  2. MED vs KRRO Comparison

MED vs KRRO Comparison

Compare MED & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$12.38

Market Cap

133.7M

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

SELL

Current Price

$13.62

Market Cap

204.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MED
KRRO
Founded
1980
2014
Country
United States
United States
Employees
N/A
57
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.7M
204.1M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
MED
KRRO
Price
$12.38
$13.62
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $20.20
AVG Volume (30 Days)
111.7K
★ 177.6K
Earning Date
10-26-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $934,842,000.00
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$56.67
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 181.46
52 Week Low
$9.22
$5.20
52 Week High
$13.45
$42.70

Technical Indicators

Market Signals
Indicator
MED
KRRO
Relative Strength Index (RSI) 55.36 70.23
Support Level $11.43 $9.43
Resistance Level $12.21 $14.69
Average True Range (ATR) 0.44 1.06
MACD 0.06 0.59
Stochastic Oscillator 38.19 94.97

Price Performance

Historical Comparison
MED
KRRO

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: